• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB

CAMBIUM BIO LIMITED

0.00% ! 46.0¢
Market Cap $12.57M  !

Cambium Bio Limited is an Australia-based clinical-stage regenerative medicine company... Cambium Bio Limited is an Australia-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue repair applications. The Company's proprietary technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. The Company’s lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. It contains enriched levels of regenerative factors, protease inhibitors, minerals and vitamins. In addition, the Company's stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It is also developing Sygenus, a preclinical secretome-based biologic for wound healing.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CMB 24/03/26 0 167
24/03/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
CMB 17/03/26 0 103
17/03/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  103 
CMB 17/03/26 0 117
Metals & Mining SECTOR NEWS

DBO - Further High-Grade Critical Minerals Results Extend Target Zones at Star Range, Utah

DBO
20 Apr 2026
DIABLO RESOURCES LIMITED
17/03/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  117 
CMB 16/03/26 0 129
16/03/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  129 
CMB 09:59 0 199
09:59 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  199 
CMB 11/02/26 0 196
11/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  196 
CMB 11/02/26 0 162
11/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  162 
CMB 23/01/26 0 237
23/01/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  237 

See All Discussions arrow Created with Sketch.

Timeline

Change of Directors Interest Notice - ST
24 Mar 16:31
 
Cleansing Notice
17 Mar 09:38
 
Application for quotation of securities - CMB
17 Mar 09:21
 
Results of General Meeting
16 Mar 13:23
 
Half Year Report and Accounts
20 Feb 09:39
 
Proposed issue of securities - CMB
11 Feb 10:52
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $12.57M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0
Last trade - 14.57pm 20/04/2026 (20 minute delay) ?
CMB (ASX) Chart
Day chart unavailable
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.